Automated description from the Alliance of Genome Resources
Predicted to have transmembrane transporter activity and ubiquitin protein ligase binding activity. Predicted to be involved in xenobiotic detoxification by transmembrane export across the plasma membrane. Predicted to localize to several cellular components, including the apical plasma membrane; integral component of plasma membrane; and nuclear envelope. Human ortholog(s) of this gene implicated in breast cancer. Orthologous to human SLC22A18 (solute carrier family 22 member 18).